AFAMELANOTIDE

AFAMELANOTIDE was reported 21 times

AFAMELANOTIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 IMPLANT SITE URTICARIA 2 0.0204
1 IMPLANT SITE HYPERSENSITIVITY 2 0.0180
2 ACUTE ON CHRONIC LIVER FAILURE 1 0.0046
3 IMPLANT SITE PRURITUS 2 0.0022
4 IMPLANT SITE REACTION 1 0.0022
5 CONTRAINDICATION TO MEDICAL TREATMENT 3 0.0020
6 PORTAL HYPERTENSIVE GASTROPATHY 1 0.0018
7 DISCOLOURED VOMIT 1 0.0010
8 IMPLANT SITE SWELLING 1 0.0010
9 IMPLANT SITE ERYTHEMA 1 0.0010
10 TYPE I HYPERSENSITIVITY 3 0.0009
11 OESOPHAGEAL VARICES HAEMORRHAGE 1 0.0005
12 VARICES OESOPHAGEAL 1 0.0003
13 ILEUS PARALYTIC 1 0.0002
14 INTESTINAL ISCHAEMIA 1 0.0002
15 MALIGNANT MELANOMA 2 0.0001
16 SHOCK HAEMORRHAGIC 1 0.0001
17 SENSATION OF FOREIGN BODY 1 0.0001
18 APPENDICITIS 1 0.0001
19 ANAPHYLACTIC REACTION 4 0.0001
20 HEPATIC CIRRHOSIS 1 0.0001
21 PRESYNCOPE 1 0.0000
22 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1 0.0000
23 ASCITES 1 0.0000
24 EPILEPSY 1 0.0000
25 METABOLIC ACIDOSIS 1 0.0000
26 HIP FRACTURE 1 0.0000
27 HYPERKALAEMIA 1 0.0000
28 CELLULITIS 1 0.0000
29 THERAPEUTIC RESPONSE DECREASED 1 0.0000
30 HEPATIC ENZYME INCREASED 1 0.0000
31 DIABETES MELLITUS 1 0.0000
32 INTENTIONAL PRODUCT MISUSE 1 0.0000
33 INTENTIONAL PRODUCT USE ISSUE 1 0.0000
34 FLUSHING 1 0.0000
35 ACUTE KIDNEY INJURY 1 0.0000
36 PERIPHERAL SWELLING 1 0.0000
37 PARAESTHESIA 1 0.0000
38 URTICARIA 1 0.0000
39 HYPOTENSION 1 0.0000
40 WEIGHT INCREASED 1 0.0000
41 VOMITING 2 0.0000
42 PNEUMONIA 1 0.0000
43 FALL 1 0.0000
44 ASTHENIA 1 0.0000
45 RASH 1 0.0000
46 MALAISE 1 0.0000
47 DIZZINESS 1 0.0000
48 DYSPNOEA 1 0.0000
49 HEADACHE 1 0.0000
50 DIARRHOEA 1 0.0000
51 NAUSEA 1 0.0000
52 DEATH 1 0.0000
53 OFF LABEL USE 1 0.0000